iShares Biotechnology ETF Rating → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free IBB Stock Alerts $133.88 +0.53 (+0.40%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends iShares Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy2.56Holdings in IBB have an aggregate rating of Moderate Buy based on 685 analyst ratings issued in the past year covering 50 companies (84.7% of the portfolio).IBB Aggregate Price Target$157.1017.35% UpsideHigh Prediction$206.78Average Prediction$157.10Low Prediction$113.85Holdings in IBB have an aggregate price target of $157.10 and a range of $113.85 to $206.78 covering 50 companies (84.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.10%AMGNAmgen$305.85+1.6%5 of 5 stars2.52$305.65 -0.1%21Short Interest ↑8.56%VRTXVertex Pharmaceuticals$455.34+2.8%4 of 5 stars2.50$438.62 -3.7%24Analyst ForecastInsider SellingNews CoverageHigh Trading Volume8.20%REGNRegeneron Pharmaceuticals$980.16+1.1%4 of 5 stars2.76$989.36 0.9%21Insider SellingHigh Trading Volume7.57%GILDGilead Sciences$64.27+0.3%5 of 5 stars2.35$83.69 30.2%17News CoverageGap DownHigh Trading Volume5.37%MRNAModerna$142.55-5.9%3 of 5 stars2.24$126.46 -11.3%17Insider Selling3.98%IQVIQVIA$219.09-1.5%4 of 5 stars2.80$257.57 17.6%15High Trading Volume3.18%BIIBBiogen$224.94+2.2%5 of 5 stars2.65$286.50 27.4%26Analyst ForecastShort Interest ↑News Coverage3.11%MTDMettler-Toledo International$1,404.09+1.5%4 of 5 stars2.14$1,257.14 -10.5%7Analyst RevisionPositive News2.07%BNTXBioNTech$100.60+1.9%2 of 5 stars2.20$111.70 11.0%10Analyst ForecastShort Interest ↓2.02%WATWaters$308.90+0.4%4 of 5 stars1.90$305.78 -1.0%10Insider BuyingAnalyst RevisionHigh Trading Volume1.85%ALNYAlnylam Pharmaceuticals$148.43-1.1%5 of 5 stars2.59$216.19 45.6%17Insider SellingHigh Trading Volume1.79%ARGXargenx$371.02+2.4%3 of 5 stars2.71$520.68 40.3%21Analyst ForecastShort Interest ↓Positive News1.66%ILMNIllumina$104.28+3.2%5 of 5 stars2.30$164.65 57.9%20Short Interest ↑1.64%GMABGenmab A/S$28.20+0.8%3 of 5 stars2.38$48.50 72.0%13Short Interest ↑1.39%BMRNBioMarin Pharmaceutical$75.07+0.8%5 of 5 stars2.57$106.11 41.3%21Insider Selling1.32%BGNEBeiGene$148.85-3.5%3 of 5 stars2.80$251.93 69.3%10Short Interest ↓News CoveragePositive News1.32%NBIXNeurocrine Biosciences$135.41-0.9%5 of 5 stars2.80$150.85 11.4%25Analyst ForecastInsider SellingHigh Trading Volume1.27%TECHBio-Techne$77.19-0.1%4 of 5 stars2.73$81.00 4.9%111.27%INCYIncyte$57.79+0.9%5 of 5 stars2.44$73.69 27.5%18Short Interest ↓Positive NewsHigh Trading Volume1.18%NTRANatera$106.53-3.3%2 of 5 stars3.00$98.47 -7.6%15Insider Selling1.17%UTHRUnited Therapeutics$275.13+1.7%5 of 5 stars2.90$309.44 12.5%10Insider SellingHigh Trading Volume1.11%SRPTSarepta Therapeutics$129.86+4.3%5 of 5 stars2.80$164.00 26.3%15Analyst ForecastHigh Trading Volume1.08%CRLCharles River Laboratories International$208.44-0.6%5 of 5 stars2.64$255.27 22.5%11Short Interest ↓Analyst RevisionNews Coverage0.94%MEDPMedpace$386.34+0.2%5 of 5 stars2.86$443.14 14.7%7Analyst ForecastInsider Selling0.84%RGENRepligen$149.09+0.6%5 of 5 stars2.89$197.75 32.6%9Positive NewsHigh Trading Volume0.72%PCVXVaxcyte$70.27+0.1%1 of 5 stars3.00$78.50 11.7%4Insider SellingPositive News0.69%BRKRBruker$65.510.0%5 of 5 stars2.50$85.00 29.8%8Short Interest ↑0.64%LEGNLegend Biotech$40.01-7.7%3 of 5 stars3.00$81.10 102.7%11High Trading Volume0.62%ITCIIntra-Cellular Therapies$67.24+2.4%5 of 5 stars2.90$90.17 34.1%10Short Interest ↑Positive News0.62%ASNDAscendis Pharma A/S$135.10-1.7%3 of 5 stars2.89$179.44 32.8%9Analyst ForecastShort Interest ↓0.61%EXELExelixis$21.69+4.4%5 of 5 stars2.59$26.13 20.4%17Insider BuyingPositive NewsGap Up0.60%BPMCBlueprint Medicines$105.56-0.8%1 of 5 stars2.53$103.94 -1.5%17Positive News0.58%CYTKCytokinetics$48.51-1.2%4 of 5 stars2.82$74.88 54.4%17Analyst Forecast0.56%HALOHalozyme Therapeutics$44.29+2.2%5 of 5 stars2.83$53.14 20.0%6Positive News0.53%RVMDRevolution Medicines$38.33+0.4%4 of 5 stars3.10$43.20 12.7%10Positive News0.53%ROIVRoivant Sciences$10.36-0.3%2 of 5 stars2.90$16.90 63.1%10Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume0.50%IONSIonis Pharmaceuticals$37.57+2.8%4 of 5 stars2.71$59.54 58.5%140.44%CRSPCRISPR Therapeutics$53.74-0.6%2 of 5 stars2.31$73.46 36.7%16Short Interest ↑Analyst Revision0.42%APLSApellis Pharmaceuticals$39.25-3.7%4 of 5 stars2.81$74.38 89.5%16Analyst ForecastAnalyst Revision0.39%ALKSAlkermes$23.40+0.8%5 of 5 stars2.50$36.78 57.2%10High Trading Volume0.39%KRYSKrystal Biotech$160.05-1.0%4 of 5 stars3.00$177.63 11.0%9Positive News0.37%MDGLMadrigal Pharmaceuticals$236.16+4.7%5 of 5 stars2.73$345.09 46.1%11Positive News0.37%BBIOBridgeBio Pharma$28.01-2.9%5 of 5 stars2.92$47.62 70.0%12Analyst ForecastAnalyst Revision0.35%CRNXCrinetics Pharmaceuticals$44.41-2.1%4 of 5 stars2.92$60.92 37.2%12Insider Selling0.34%INSMInsmed$55.05-3.4%3 of 5 stars3.00$56.38 2.4%16Analyst ForecastInsider SellingShort Interest ↑Analyst RevisionNews Coverage0.31%RAREUltragenyx Pharmaceutical$40.14+3.9%5 of 5 stars2.93$90.67 125.9%14Analyst ForecastNews CoveragePositive NewsHigh Trading Volume0.29%ARWRArrowhead Pharmaceuticals$22.95+0.7%4 of 5 stars2.78$50.00 117.9%9Gap Up0.29%AXSMAxsome Therapeutics$73.43-1.1%5 of 5 stars2.92$121.92 66.0%13Insider Selling0.27%XENEXenon Pharmaceuticals$38.07-2.5%2 of 5 stars3.00$59.11 55.3%9Options VolumePositive NewsHigh Trading Volume0.27%PTCTPTC Therapeutics$36.36+1.5%3 of 5 stars2.07$35.67 -1.9%14Analyst Forecast This page (NASDAQ:IBB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
